Daxor Total Liabilities 2010-2011 | DXR

Daxor total liabilities from 2010 to 2011. Total liabilities can be defined as the total value of all possible claims against the corporation.
Daxor Annual Total Liabilities
(Millions of US $)
2011 $50
2010 $44
2009 $28
Daxor Quarterly Total Liabilities
(Millions of US $)
2011-12-31 $50
2011-09-30 $51
2011-06-30 $51
2011-03-31 $47
2010-12-31 $44
2010-09-30 $38
2010-06-30 $37
2010-03-31 $40
2009-12-31 $28
2009-09-30 $29
2009-06-30 $30
2009-03-31 $30
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.046B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.090B 10.34
Quest Diagnostics (DGX) United States $15.124B 15.63
DaVita (DVA) United States $11.914B 14.80
Chemed (CHE) United States $8.670B 26.88
Encompass Health (EHC) United States $8.587B 21.98
Elanco Animal Health (ELAN) United States $8.345B 21.65
Option Care Health (OPCH) United States $5.253B 19.88
RadNet (RDNT) United States $3.741B 77.89
Amedisys (AMED) United States $3.074B 21.78
LifeStance Health (LFST) United States $2.668B 0.00
Astrana Health (ASTH) United States $2.134B 28.86
Addus HomeCare (ADUS) United States $1.753B 25.08
U.S Physical Therapy (USPH) United States $1.566B 41.90
Pennant (PNTG) United States $0.665B 35.14
Aveanna Healthcare Holdings (AVAH) United States $0.466B 0.00
Atai Life Sciences (ATAI) Germany $0.337B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.020B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.012B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00